FERDINANDOS SKOULIDIS to Angiogenesis Inhibitors
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about Angiogenesis Inhibitors.
Connection Strength
0.012
-
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients. Cancer Biomark. 2009; 5(4):167-75.
Score: 0.012
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.